Identifying agents for decreasing cellular toxicity associated with huntingin polypeptide

作者: Paul J. Muchowski , Flaviano Giorgini

DOI:

关键词:

摘要: Methods of screening candidate agents to identify potential therapeutic for the treatment a neurodegenerative disease, such as Huntington's Disease and Parkinson's methods identifying mutation in, or changes in expression of, gene associated with Disease, are provided.

参考文章(28)
Flavio Moroni, Raffaella Carpenedo, Andrea Cozzi, Elena Meli, Alberto Chiarugi, Domenico E. Pellegrini-Giampietro, Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage. Advances in Experimental Medicine and Biology. ,vol. 527, pp. 127- 136 ,(2003) , 10.1007/978-1-4615-0135-0_15
Flavio Moroni, Andrea Cozzi, Fiamma Peruginelli, Neuroprotective Effects of Kynurenine-3-Hydroxylase Inhibitors in Models of Brain Ischemia Advances in Experimental Medicine and Biology. ,vol. 467, pp. 199- 206 ,(1999) , 10.1007/978-1-4615-4709-9_26
James F. Gusella, Marcy E. MacDonald, Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease Nature Reviews Neuroscience. ,vol. 1, pp. 109- 115 ,(2000) , 10.1038/35039051
Paul J. Muchowski, Susan L. Lindquist, Tiago Outeiro, Methods of identifying lead compounds that modulate toxicity of neurotoxic polypeptides ,(2004)
D Dailey, G L Schieven, M Y Lim, H Marquardt, T Gilmore, J Thorner, G S Martin, Novel yeast protein kinase (YPK1 gene product) is a 40-kilodalton phosphotyrosyl protein associated with protein-tyrosine kinase activity. Molecular and Cellular Biology. ,vol. 10, pp. 6244- 6256 ,(1990) , 10.1128/MCB.10.12.6244
Sylvia Krobitsch, Susan Lindquist, Tiago Fleming Outeiro, Yeast screens for treatment of human disease ,(2002)
Jean-Christophe Rochet, Peter T Lansbury, Amyloid fibrillogenesis: themes and variations. Current Opinion in Structural Biology. ,vol. 10, pp. 60- 68 ,(2000) , 10.1016/S0959-440X(99)00049-4
T. Munder, A. Hinnen, Yeast cells as tools for target-oriented screening. Applied Microbiology and Biotechnology. ,vol. 52, pp. 311- 320 ,(1999) , 10.1007/S002530051525
R Schwarcz, The kynurenine pathway of tryptophan degradation as a drug target. Current Opinion in Pharmacology. ,vol. 4, pp. 12- 17 ,(2004) , 10.1016/J.COPH.2003.10.006